A total of 19,114 persons with a median age of 74 years were enrolled in a study, reported in the September 16, 2018 issue of the New England Journal of Medicine.
9525 were randomly assigned to receive aspirin and 9589 to receive placebo. The rate of major hemorrhage was higher in the aspirin group than in the placebo group. The study concluded that aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years.
The take away? Daily use of…READ ARTICLE